James Shin

Stock Analyst at Deutsche Bank

(3.29)
# 1,059
Out of 5,044 analysts
22
Total ratings
60%
Success rate
16.46%
Average return

Stocks Rated by James Shin

Eli Lilly and Company
Aug 11, 2025
Maintains: Buy
Price Target: $1,010$900
Current: $820.10
Upside: +9.74%
Immatics
May 28, 2025
Initiates: Buy
Price Target: $10
Current: $10.35
Upside: -3.38%
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80$120
Current: $117.88
Upside: +1.80%
Merck & Co.
Feb 18, 2025
Downgrades: Hold
Price Target: $128$105
Current: $87.03
Upside: +20.65%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310$305
Current: $292.09
Upside: +4.42%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55$60
Current: $91.65
Upside: -34.53%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53$45
Current: $42.82
Upside: +5.09%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $32.57
Upside: +84.22%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $227.54
Upside: -34.08%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $654.48
Upside: +22.23%
Initiates: Buy
Price Target: $10
Current: $1.54
Upside: +549.35%
Initiates: Buy
Price Target: $12
Current: $1.11
Upside: +985.97%